Guizhounli Pharmaceutical Co (SHSE:603439) Cash Flow for Dividends : ¥-104 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Guizhounli Pharmaceutical Co Cash Flow for Dividends?

Guizhounli Pharmaceutical Co's cash flow for dividends for the three months ended in Mar. 2025 was ¥-5 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-104 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Guizhounli Pharmaceutical Co's quarterly payment of dividends declined from Sep. 2024 (¥-6 Mil) to Dec. 2024 (¥-5 Mil) but then increased from Dec. 2024 (¥-5 Mil) to Mar. 2025 (¥-5 Mil).

Guizhounli Pharmaceutical Co's annual payment of dividends increased from Dec. 2022 (¥-9 Mil) to Dec. 2023 (¥-51 Mil) and increased from Dec. 2023 (¥-51 Mil) to Dec. 2024 (¥-104 Mil).

Guizhounli Pharmaceutical Co Cash Flow for Dividends Historical Data

The historical data trend for Guizhounli Pharmaceutical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhounli Pharmaceutical Co Cash Flow for Dividends Chart

Guizhounli Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Dividends

Get a 7-Day Free Trial

-2.62

-110.21

-8.93

-50.92

-104.04

Guizhounli Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash Flow for Dividends	Get a 7-Day Free Trial															-5.81	-87.04	-6.01	-5.19	-5.33

Guizhounli Pharmaceutical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-104 Mil.

Guizhounli Pharmaceutical Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Guizhounli Pharmaceutical Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhounli Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guizhou Sanli Pharmaceutical Co Ltd (SHSE:603439) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xiayun Industrial Park, Pingba District, Guizhou Province, Anshun, CHN, 561000

Website

http://www.gz-sanli.com

Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.

Executives

Zhang Hai	Director
Wang Jue Ben	senior management
Zhang Hong Yu	Directors, senior managers
Wang Yi	senior management
Zhang Qian Fan	Directors, senior managers
Sheng Yong Jian	Director

Guizhounli Pharmaceutical Co Headlines

No Headlines